ASH® 20 Annual Meeting Review
Saturday, December 12th, 2020
Saturday, December 19th, 2020
No Registration Fee for Healthcare Providers
- Nurse Practitioners and Physician Assistants
- Residents and Fellows
- Researchers and others involved in the management of patients with blood disorders and hematologic malignancies
At the conclusion of the activity, participants will be able to:
- Discuss new and updated treatment options for patients with blood disorders and hematologic malignancies
- Identify side effects, indications, and contra-indications of various therapies used to diagnose and treat blood disorders and hematologic malignancies, and explain how to effectively manage those side-effects
- Summarize diagnostic and treatment-related data relevant to multidisciplinary care
- Review data presented at the 62nd ASH Annual Meeting (2020) and discuss their application in clinical settings
CME Credit Statement
The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians.
The Binaytara Foundation designates this live activity for a maximum of 6 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the criteria for up to 6 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
Nursing Continuing Education Credits – Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 6 Contact Hours.
How to claim your CME or CE credits:
If you participated in this CME activity either 12/12/20 or 12/19/20, you should have received an email from the program chairs for each day about completing the post-activity evaluation. Please complete the evaluation by 12/31/20 to claim your credits. If you did not receive the evaluation for one or both days, please email – [email protected].
Commercial Support Acknowledgement
This activity has been supported by independent medical education grant from the following organizations:
- Dova Pharmaceuticals
- Bristol Myers Squibb
- Jazz Pharmaceuticals
Dr. Shaji Kumar
Mayo School of Medicine
Dr. Doris Quon
Orthopedic Hemophilia Treatment Center
Dr. Andrew Cowan
University of Washington
Disclosure of Off-label product
This educational activity may or may not contain discussions of investigational, unapproved, or off-label products. Participants should consult prescribing information for products discussed during these meetings. Faculties will disclose at the time of presentation if any off-level product being discussed.
Disclosure of Conflict of Interest
The Binaytara Foundation collects disclosure information from all faculty and organizing committee members involved in planning, implementation, and evaluation of our continuing medical education activities. All conflict will be identified and resolved for everyone in control of the contents of this activity before their participation in this educational activity.
No member of the activity planning committee has any relevant financial relationship with an ACCME defined commercial interest.
Faculty disclosure of relevant financial relationship will be provided to participants during the meeting. Participants can also request a copy of the faculty disclosure ahead of time once the information about Continuing Medical Education Credits is made available. Please contact [email protected] to request the disclosures.
Registration is now open. Please click here to navigate to our registration page.